The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 13 members with Joerg Reinhardt as chair.

Download the Board of Director Committee Organizational Chart (PDF 0.1 MB)

Joerg Reinhardt, Ph.D., Chairman of the Board of Directors
Chair
Joerg Reinhardt, Ph.D.
Simon Moroney, Member of the Board of Directors
Board member since February 28, 2020 | Vice Chair since March 4, 2022
Simon Moroney, D.Phil.
Nancy C. Andrews, M.D., Ph.D., Member of the Board of Directors
Board member since 2015
Nancy C. Andrews, M.D., Ph.D.
Ton Buechner, Member of the Board of Directors
Board member since 2016
Ton Buechner
Patrice Bula, Member of the Board of Directors
Board member since February 28, 2019 | Lead Independent Director since March 4, 2022
Patrice Bula
Elizabeth (Liz) Doherty, Member of the Board of Directors
Board member since 2016
Elizabeth (Liz) Doherty
Ana de Pro Gonzalo
Board member since March 4, 2022
Ana de Pro Gonzalo
Bridgette Heller, Member of the Board of Directors
Board member since February 28, 2020
Bridgette Heller
Daniel Hochstrasser
Member of the Board of Directors since March 4, 2022
Daniel Hochstrasser
Frans van Houten, Member of the Board of Directors
Board member since 2017
Frans van Houten
Andreas von Planta, Ph.D., Member of the Board of Directors
Board member since 2006
Andreas von Planta, Ph.D.
Charles L. Sawyers, M.D., Member of the Board of Directors
Board member since 2013
Charles L. Sawyers, M.D.
William T. Winters, Member of the Board of Directors
Board member since 2013
William T. Winters
Charlotte Pamer-Wieser, Ph.D., Corporate Secretary
Corporate Secretary
Charlotte Pamer-Wieser, Ph.D.